Changemakers in cancer: Jessica Taylor
15 July 2024Dr Jessica Taylor’s ambition is to change the outcome of paediatric brain cancer. She wants children not just to survive but to survive well.
Dr Jessica Taylor’s ambition is to change the outcome of paediatric brain cancer. She wants children not just to survive but to survive well.
As a young medical student in Nigeria, Segun was shocked by the disproportionate rate of death from treatable cancers across Africa. To help bring about change, he’s supporting knowledge sharing and skills training for students in Africa. He also co-founded an initiative to provide career guidance and mentoring for schoolchildren in Nigeria. In Cambridge, he hopes his PhD will lead to a way to enhance immune cells to deliver a ‘kiss of death’ to cancer.
Work will begin soon on a new hospital that will transform how we diagnose and treat cancer. Cambridge Cancer Research Hospital will treat patients across the East of England, but the research that takes place there promises to change the lives of cancer patients across the UK and beyond.
Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.
After being transferred to Cambridge by the Hawking Family in 2021, the scientific and personal archive of Professor Stephen Hawking has been fully catalogued and is now available to all who might benefit from access to it at Cambridge University Library.
Jenny Gallop uses frog egg extract to figure out key cellular processes - which has helped understand and potentially treat two rare genetic diseases in humans.
On World Population Day, University of Cambridge researchers bust some of the biggest myths about life in England since the Middle Ages, challenging assumptions about everything from sex before marriage to migration and the health/wealth gap.
The 1924 Paris Olympics stars in a major Fitzwilliam Museum exhibition exploring the sport, art and bodies behind a pivotal Games. Exhibits speak of surprising partnerships, competing interests and unresolved tensions.
Five Cambridge researchers join the community of over 2,100 leading life scientists today as the European Molecular Biology Organisation (EMBO) announces its newest Members in its 60th anniversary year.
Artificial intelligence (AI) could be used to identify drug resistant infections, significantly reducing the time taken for a correct diagnosis, Cambridge researchers have shown. The team showed that an algorithm could be trained to identify drug-resistant bacteria correctly from microscopy images alone.